Our Team

Dr. Konstantinos Alevizopoulos | Partner

Dr. Konstantinos Alevizopoulos is a preclinical expert with significant expertise in the identification, licensing and development of early therapeutic and diagnostic leads in the life sciences sector. While implementing key preclinical research & development strategies, Dr. Alevizopoulos has worked closely with leading academic institutions, teaching hospitals and CROs around the globe to create significant shareholder value and forward potential for investors.

Important positions in his curriculum outside Ventac Partners include: his current position as a Chief Executive Officer of APIM Therapeutics AS (NO) and previous assignments including Managing Director of Medexis SA (GR), Chief Scientific Officer of Gerolymatos International SA (GR), Head of Preclinical R & D of Biovista Inc. (US) and Head of R & D of Apotech Corporation (CH). Dr Alevizopoulos is also a founding partner and Vice Presidnet of the Hellenic  Biotechnology Cluster Association (GR).

Dr. Alevizopoulos received his Biology degree from the University of Athens, Greece and his Ph.D. in Molecular Biology from the University of Lausanne, Switzerland. He has also conducted post-doctoral studies in the Swiss Institute of Experimental Cancer Research (Switzerland) and the Schering Plough Research Institute (USA) specializing in preclinical oncology research. Dr. Alevizopoulos is trained in European Patent Law (Robert Schuman University of Strasbourg, France).

Konstantinos Alevizopoulos, PhD
Partner